Page last updated: 24-JUN-2008
Skin Cancers
Data analyses and reports
-
-
A
summary table of the main statistics for malignant melanoma of the skin.
-
Cancer in Scotland Summary 
[264KB] is an overview of cancer in Scotland focusing on incidence, mortality and survival for the main cancer sites.
-
-
-
Cancer Research UK factsheets provide detailed analyses and interpretation of cancer data.
-
-
Malignant melanoma of the skin: ICD-10 C43
| Incidence: |
Annual incidence [309KB] (1980 onwards) by age, sex, network and health board |
|
Five year summary of incidence [48KB] by age, sex, network and health board |
| Mortality: |
Annual mortality [300KB] (1980 onwards) by age, sex, network and health board |
|
Five year summary of mortality [49KB] by age, sex, network and health board |
| Survival: |
Survival [33KB] (by age and sex) at 1, 3, 5 & 10 years after diagnosis (1980 onwards) |
|
Survival summary [450KB] and interpretation at 1 & 5 years after diagnosis (1980 onwards) |
| Prevalence: |
Cancer prevalence [17KB] |
| Lifetime risk: |
Lifetime risk [16KB] of cancer by age and sex |
| Deprivation: |
Chart [17KB] of incidence, mortality and survival by deprivation category |
Non-melanoma skin cancer: ICD-10 C44
Basal cell carcinoma: ICD-10 C44 M-809
Squamous cell carcinoma: ICD-10 C44 M-807
Summary statistics for malignant melanoma of the skin
| Scotland |
Males |
Females |
| Rank |
9 |
7 |
| Percentage frequency of all cancers |
3.1% |
3.3% |
| Number of new cases diagnosed in 2005 |
393 |
454 |
| Number of deaths recorded in 2006 |
90 |
68 |
| Change in incidence from 1995 to 2005 |
+43.2% |
+20.1% |
| Change in mortality from 1996 to 2006 |
+28.9% |
+9.3% |
| 1 year relative survival for patients diagnosed between 2000 and 2004 |
95.4% |
98.4% |
| 5 year relative survival for patients diagnosed between 2000 and 2004 |
86.5% |
92.8% |
Notes:
1. Non-melanoma skin cancer is often excluded from comparative analyses of cancer data, both because of concerns about the completeness of registration and a perception that cancers of this kind are rarely life threatening. Most non-melanoma skin cancers are detected early and can be treated on an outpatient basis (the lack of a discharge record for such patients is one of the reasons why registration of new cases is less complete than for other cancers, most of which involve hospitalisation).
2. Survival figures are not age standardised.
3. Change in incidence and mortality is estimated by Poisson regression.